PATENT LITERATURE REVIEW OF OPHTHALMIC INSERTS

In the area of topical ocular administration, important efforts concern the design and the conception of new ophthalmic drug delivery systems able to prolong the residence time. The use of inserts, which are solid devices to be placed in the cul-the-sac or on the cornea represents one of the possibilities to reach increased residence time. These solid ophthalmic devices present the advantage of avoiding a pulsed release due to multiple applications. In the scientific literature, patents are often not mentioned resource and this remark is particularly true in the case of ophthalmic inserts: there is no review yet describing patented ophthalmic inserts. Thus the review presented herein essentially takes into account patented ophthalmic inserts. The solid ophthalmic devices are classified into three major categories based upon their solubility behavior: the insoluble, the soluble and the bioerodible inserts. When necessary, these groups are subdivided into more specific sub-groups. The discussion essentially takes into account the design, the conception, the release mechanisms, the in vivo and in vitro assays, the limitations, and the therapeutic rationale for their use.

[1]  M. Refojo,et al.  Perfluoro-1-methyldecalin as a potential oxygen carrier with fluid scleral lenses. , 1985, Current eye research.

[2]  L. Desantis,et al.  Inlfuence of high-viscosity vehicles on miotic effect of pilocarpine. , 1978, Journal of pharmaceutical sciences.

[3]  A. Ludwig,et al.  Evaluation of viscous ophthalmic vehicles containing carbomer by slit-lamp fluorophotometry in humans , 1990 .

[4]  M. Busin,et al.  Sustained gentamicin release by presoaked medicated bandage contact lenses. , 1988, Ophthalmology.

[5]  P. K. Sehgal,et al.  Collagen ophthalmic inserts for pilocarpine drug delivery system , 1988 .

[6]  J. Prydal,et al.  Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy , 1990, Eye.

[7]  M. F. Saettone,et al.  Semisolid ophthalmic vehicles. III. An evaluation of four organic hydrogels containing pilocarpine , 1986 .

[8]  A. Robin,et al.  Reformulation and drop size of apraclonidine hydrochloride. , 1992, American journal of ophthalmology.

[9]  Shell Jw,et al.  Diffusional systems for controlled release of drugs to the eye. , 1974 .

[10]  A. Urtti,et al.  Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release studies , 1992 .

[11]  R. Gurny,et al.  Aqueous nanodispersions prepared by a salting-out process , 1992 .

[12]  S. Shirolkar,et al.  Sustained release ophthalmic formulations of pilocarpine , 1989, The Journal of pharmacy and pharmacology.

[13]  C. Wilson Scintigraphic Evaluation of Polymeric Formulations for Ophthalmic Use , 1987 .

[14]  D. Pavan-Langston,et al.  Pilocarpine ocusert system for sustained control of ocular hypertension. , 1975, Archives of ophthalmology.

[15]  R. Gurny,et al.  Concept and development of ophthalmic pseudo-latexes triggered by pH , 1991 .

[16]  S. Klyce,et al.  The effects of contact lenses on the normal physiology and anatomy of the cornea: symposium summary , 1985 .

[17]  J. Hadgraft,et al.  Drug release from Pluronic F-127 gels , 1986 .

[18]  R. Gurny,et al.  Latices and Thermosensitive Gels as Sustained Delivery Systems to the Eye , 1987 .

[19]  Susan C. Miller,et al.  Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits , 1982 .